Newell Brands (Nasdaq: NWL) might not be a household name itself, but its products certainly are.
The company owns a powerful portfolio of consumer goods brands including Rubbermaid, Sharpie, Coleman, Yankee Candle, and many others. With more than 25...
Editor’s Note: Our friend Karim Rahemtulla does a fantastic job of helping his readers stay grounded while most other investors are panicking.
So today, I’m sharing Karim’s best tips for position sizing and protecting your wealth when markets look...
Energy Transfer (NYSE: ET) is a favorite among income investors due to its strong yield.
And now, thanks to the meltdown in the markets, the stock yields nearly 8%, making it even more attractive.
But can investors rely on that...
Your last name doesn’t have to be Einstein or Buffett to understand that the markets nosedived last week on news that the U.S. would impose tariffs on all foreign goods.
Consider:
The new tariffs are the largest tax increase since...
Editor’s Note: With President Trump’s “Liberation Day” tariffs sending the markets into a tailspin, I decided to share this column Chief Income Strategist Marc Lichtenfeld wrote several years ago in lieu of a new Value Meter today.
The S&P...
Editor’s Note: The Oxford Club has the pleasure of working with TradeSmith CEO Keith Kaplan, a man whose customers track $30 billion with his work.
He recently told us about his biggest new breakthrough in 20 years…
A website you...
When you look at a stock chart, it seems reasonable to assume that if the price is going up, then the company must be doing well.
And right now, AT&T‘s (NYSE: T) price is certainly going up.
Since October 2023,...
There are a lot of different investment strategies. My favorite is to swing for the fences. The more speculative, the better. After all, if one of my trades hits, riches abound.
Crypto, penny stocks, jumping on the latest trend…...
Crispr Therapeutics (Nasdaq: CRSP) stands at the forefront of gene-editing technology, aiming to develop revolutionary treatments for serious diseases.
The company recently achieved a significant milestone with the approval of Casgevy, the world’s first CRISPR-based therapy, which treats sickle...
You always remember your first…
I’m talking about investments, of course. What did you think I was referring to?
I bought my first stock in 1990. It was Harley-Davidson (NYSE: HOG). I bought 50 shares at $12. Three months later,...
